Acute and sub-acute toxicity of ethanol extracts of Hagenia abyssinica and Rumex abyssinicus flowers in Swiss albino mice
- PMID: 39999122
- PMCID: PMC11856396
- DOI: 10.1371/journal.pone.0319464
Acute and sub-acute toxicity of ethanol extracts of Hagenia abyssinica and Rumex abyssinicus flowers in Swiss albino mice
Abstract
Background: Hagenia abyssinica (Bruce) J.F. Gmel (Family: Rosaceae) and Rumex abyssinicus Jacq (Family: Polygonaceae) are valuable medicinal plants traditionally used in Ethiopia to treat various diseases. Recent studies have also demonstrated that solvent extracts of these plants exhibit molluscicidal activities under laboratory conditions, highlighting their potential for snail control. However, limited information is available regarding their safety profiles.
Objective: This study aimed to evaluate acute, and sub-acute toxicity of 70% ethanol extracts of H. abyssinica and R. abyssinicus flowers in Swiss albino mice, following the Organization for Economic Co-operation and Development guidelines 423 and 407.
Methods: In the acute toxicity study, both extracts were administered orally to experimental groups at varying concentrations (mg/kg bodyweight): 5, 50, 300, and 2000. For the sub-acute toxicity study, both extracts were given to the experimental groups at doses (mg/kg) of 125, 250, and 500 daily for 28 days. Blood samples were collected from each mouse and analyzed for hematological and biochemical parameters. Additionally, the heart, liver, and kidneys were excised, stained, and examined for potential histopathological effects.
Results: The acute toxicity study revealed no noticeable changes in behavior at the highest oral dosage of 2000 mg/kg. In the sub-acute toxicity study, no statistically significant changes were observed in hematological and biochemical parameters compared to the control group. Similarly, no abnormal histological findings were noted in the examined organs in comparison to the control group.
Conclusion: These findings indicate that flower extracts of both plants did not show significant toxicity to laboratory mammals at an oral dosage of 2000 mg/kg.
Copyright: © 2025 Gemeda et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Conflict of interest statement
The authors have declared that no competing interests exist.
Figures
References
-
- Sturrock RF. The schistosomes and their intermediate hosts. In: Mahmoud AAF, editor. Schistosomiasis. London: Imperial College Press; 2001.
-
- Coon DR. Schistosomiasis: overview of the history, biology, clinicopathology, and laboratory diagnosis. Clin Microbiol Newsl. 2005;27(21):163–8. doi: 10.1016/j.clinmicnews.2005.10.001 - DOI
-
- Zoni AC, Catala L, Ault SK. Schistosomiasis prevalence and intensity of infection in Latin America and the Caribbean countries, 1942-2014: a systematic review in the context of a regional elimination goal. PLoS NeglTrop Dis. 2016;10(3):e0004493. doi: 10.1371/journal.pntd.0004493 - DOI - PMC - PubMed
-
- World Health Organization. Schistosomiasis and soil-transmitted helminthiases: progress report, 2022. Wkly Epidemiol Rec. 2023;98(51):667–76. [cited 15 Sep 2024]. Available from: https://www.who.int/publications/i/item/who-wer9851-667-676
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials
